Lexeo Therapeutics (LXEO) Profit After Tax: 2022-2023
Historic Profit After Tax for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2023 value amounting to -$14.2 million.
- Lexeo Therapeutics' Profit After Tax rose 2.79% to -$14.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$66.4 million, marking a year-over-year change of. This contributed to the annual value of -$98.3 million for FY2024, which is 48.09% down from last year.
- Per Lexeo Therapeutics' latest filing, its Profit After Tax stood at -$14.2 million for Q4 2023, which was up 29.42% from -$20.1 million recorded in Q3 2023.
- Over the past 5 years, Lexeo Therapeutics' Profit After Tax peaked at -$13.4 million during Q2 2023, and registered a low of -$20.1 million during Q3 2023.
- Moreover, its 2-year median value for Profit After Tax was -$15.8 million (2022), whereas its average is -$16.3 million.
- The largest annual percentage gain for Lexeo Therapeutics' Profit After Tax in the last 5 years was 2.79% (2023), contrasted with its biggest fall of 17.90% (2023).
- Lexeo Therapeutics' Profit After Tax (Quarterly) stood at -$14.6 million in 2022, then increased by 2.79% to -$14.2 million in 2023.
- Its Profit After Tax was -$14.2 million in Q4 2023, compared to -$20.1 million in Q3 2023 and -$13.4 million in Q2 2023.